1. Home
  2. YJ vs KZIA Comparison

YJ vs KZIA Comparison

Compare YJ & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YJ
  • KZIA
  • Stock Information
  • Founded
  • YJ 2015
  • KZIA 1994
  • Country
  • YJ China
  • KZIA Australia
  • Employees
  • YJ N/A
  • KZIA N/A
  • Industry
  • YJ Other Specialty Stores
  • KZIA Biotechnology: Pharmaceutical Preparations
  • Sector
  • YJ Consumer Discretionary
  • KZIA Health Care
  • Exchange
  • YJ Nasdaq
  • KZIA Nasdaq
  • Market Cap
  • YJ 8.8M
  • KZIA 6.0M
  • IPO Year
  • YJ 2019
  • KZIA 1999
  • Fundamental
  • Price
  • YJ $1.76
  • KZIA $0.89
  • Analyst Decision
  • YJ
  • KZIA Strong Buy
  • Analyst Count
  • YJ 0
  • KZIA 2
  • Target Price
  • YJ N/A
  • KZIA $11.50
  • AVG Volume (30 Days)
  • YJ 37.0K
  • KZIA 5.5M
  • Earning Date
  • YJ 03-20-2025
  • KZIA 03-26-2025
  • Dividend Yield
  • YJ N/A
  • KZIA N/A
  • EPS Growth
  • YJ N/A
  • KZIA N/A
  • EPS
  • YJ N/A
  • KZIA N/A
  • Revenue
  • YJ $66,957,730.00
  • KZIA $1,655,324.00
  • Revenue This Year
  • YJ N/A
  • KZIA $806.89
  • Revenue Next Year
  • YJ N/A
  • KZIA N/A
  • P/E Ratio
  • YJ N/A
  • KZIA N/A
  • Revenue Growth
  • YJ N/A
  • KZIA 248000.00
  • 52 Week Low
  • YJ $1.42
  • KZIA $0.89
  • 52 Week High
  • YJ $4.72
  • KZIA $15.80
  • Technical
  • Relative Strength Index (RSI)
  • YJ 50.71
  • KZIA 28.96
  • Support Level
  • YJ $1.65
  • KZIA $0.90
  • Resistance Level
  • YJ $1.75
  • KZIA $1.60
  • Average True Range (ATR)
  • YJ 0.12
  • KZIA 0.24
  • MACD
  • YJ -0.01
  • KZIA 0.01
  • Stochastic Oscillator
  • YJ 39.29
  • KZIA 0.00

About YJ Yunji Inc. American Depository Shares

Yunji Inc is a social e-commerce platform in China that offers a membership-based model that leverages the power of social interaction. The company provides a host of selected commodities such as beauty and personal care, mobile phones and digital products, baby and maternal products, toys, fruits, and other fresh products. It has expanded to operate its business, including the marketplace, on a diverse range of sales channels and other platforms. Geographically, the firm operates in China.

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.

Share on Social Networks: